DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/12179| Title: | Increased SARS-CoV-2-related hospitalization and mortality in rheumatoid arthritis patients receiving rituximab therapy-a monocentric retrospective study |
| Authors: | Wang, Chrong-Reen Hsu, Chih-Hui Lin, Wei-Chieh |
| Keywords: | SARS-CoV-2 Rheumatoid arthritis Rituximab Hospitalization COVID19 pneumonia Mortality |
| Issue Date: | Jan-2025 |
| Publisher: | Elsevier Taiwan LLC |
| Abstract: | From 2022 April to 2024 August, retrospective analyses by multivariable logistic regression were conducted in 341 rheumatoid arthritis patients receiving rituximab (RTX), tofacitinib (TOF) or disease-modifying-antirheumatic drug (DMARD) alone therapy. Compared to DMARD alone or TOF treatment, RTX therapy had increased adjusted odds ratios of SARS-CoV-2-related hospitalization, pneumonia and mortality |
| URI: | http://localhost:8080/xmlui/handle/123456789/12179 |
| Appears in Collections: | Vol 58 No 2 (2025) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Increased-SARS-CoV-2-related-hospitalization-and-morta_2025_Journal-of-Micro.pdf | 924.05 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.